Anna Matyjek - Publications

Validation of albuminuria as a surrogate endpoint in chronic kidney disease: clinical context and implications.

Journal: Clinical kidney journal

Published: February 13, 2026

Beyond Biochemical Markers: Characterizing Malnutrition in COVID-19.

Journal: Nutrients

Published: October 17, 2025

Cardiovascular disease and risk management in patients with nephrotic syndrome.

Journal: Kidney research and clinical practice

Published: June 20, 2025

Longitudinal Trajectories of Kidney Function in Patients with Severe ANCA-Associated Vasculitis.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: January 23, 2025

Antibody-mediated podocytopathies: a disease entity that implies immunotherapy.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: June 21, 2024

Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies.

Journal: Journal of the American Society of Nephrology : JASN

Published: June 16, 2024

The impact of severe nephrotic syndrome on thyroid function, nutrition and coagulation.

Journal: Clinical kidney journal

Published: April 15, 2024

Metanalyses on metformin's role in pancreatic cancer suffer from severe bias and low data quality - An umbrella review.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: November 09, 2022

Testosterone Replacement Therapy in Chronic Kidney Disease Patients.

Journal: Nutrients

Published: July 22, 2022

Free testosterone levels and their association with body composition in women with chronic kidney disease.

Journal: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego

Published: November 20, 2021

Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome-A Single Center Prospective Study.

Journal: Journal of clinical medicine

Published: November 11, 2021

Serum Osteoprotegerin Is an Independent Marker of Metabolic Complications in Non-DialysisDependent Chronic Kidney Disease Patients.

Journal: Nutrients

Published: September 05, 2021